Myovant Sciences Ltd. (41) | Investor Rights Agreements (1)
- Investor Rights Agreement, dated as of December 27, 2019, by and among the Registrant, Sumitovant Biopharma Ltd. and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 10, 2020)
© 2022 Justia
